Sponsor

2016/03/23

Are Any Public Traded Hedge Funds Worth Owning?

The media has talked a lot about the carnage among hedge funds recently, but some everyday investors are living it firsthand as well.

Daily Profit Newsletter

 

Wednesday, March 23, 2016

 

 

Are Any Public Traded Hedge Funds Worth Owning?
by Marshall Hargrave

 

The media has talked a lot about the carnage among hedge funds recently, but some everyday investors are living it firsthand as well. That's not because they've directly invested in the big-name hedge funds, but because they've used public hedge fund vehicles to invest alongside the likes of Bill Ackman and Carl Icahn.

 

Unbeknownst to many, Bill Ackman, Carl Icahn and a host of other billionaires have public investment vehicles that mirror the stocks the fund managers are buying.

 

These publicly traded hedge funds are a way for hedge fund managers to get access to the capital markets to grow their assets, but it also gives them more stability by offering permanent capital.

 

Carl Icahn's public vehicle is Icahn Enterprises LP (NASDAQ: IEP), while Bill Ackman has Pershing Square Holdings (OTC: PSHZF).

 

------Recommended Reading------

How to make 11% profits...in just 7 days

 

Would you like to earn quick profits every week?

 

Discover how to win 89% of these 7-day trades...earning an average profit of 11%! Let us show you the strategy...share 4 live trade examples...and answers all of your questions.

 

We'll show you everything in just 1-hour.

 

Click here now for all the details.

-------------------------------

 

But just as these hedge funds have taken a beating in their portfolios, so have these publicly traded entities. Units of Icahn Enterprises have fallen 27% in the last year, while Pershing Square is down more than 40%.

 

Pershing's pain is in large part driven by its stake in Valeant Pharmaceuticals International (NYSE: VRX), which has fallen 85% in the last 12 months.

 

Still Too Soon

 

For investors looking to bottom feed in these hedge fund vehicles, it still might be too early, although both Icahn and Ackman are great investors. Ackman has a long-term record that dwarfs the broader market. He's averaged annualized returns of more than 17% since 2004, while the S&P 500 return was just 7% over the same period.

 

Icahn Enterprises does pay a dividend, which yields 9.2%. But Icahn Enterprises was put on notice last month by Standard & Poor's that its credit rating might be downgraded to junk status.

 

The problem for Icahn hasn't been just one stock, but a few in the commodity industry. Three of his biggest bets are Chesapeake Energy (NYSE: CHK), Freeport McMoRan (NYSE: FCX) and Cheniere Energy (NYSE: LNG), which are all down more than 40% in the last 12 months. 

 

Ackman isn't doing any better. He got notice this week that Standard & Poor's is also thinking of cutting his fund's credit rating due to its fall in net asset value. Pershing Square's NAV has fallen from $5.3 billion in October to its present level of $3.8 billion.

 

Pershing appears to be trying to shore up its balance sheet, as evidenced by its trimming of its stake in Mondelez International (NASDAQ: MDLZ) last week. Still, it's not clear how the Valeant stake will shake out, with fears lingering that the company could default on its debt.

 

As for Icahn, his big bets on the commodity industry haven't played out, and he's very beholden to commodity prices, which are proving increasingly volatile.

 

Enough Pain to Go Around

 

Now, there are two other hedge fund managers with public vehicles, both of which are reinsurers.

 

First is Dan Loeb's Third Point Reinsurance Ltd. (NYSE: TPRE), which is down 20% in the last year.

 

Then there's David Einhorn's Greenlight Capital Re Ltd. (NASDAQ: GLRE), which has fallen more than the Icahn and Loeb vehicles. It's off 33% over the last year.

 

It appears that Einhorn is on the right track so far this year, with his fund up 3.3% through February. This comes as Einhorn made some major changes heading into 2016. He sold off key losers like SunEdison (NYSE: SUNE) and Micron Technology (NASDAQ: MU). Meanwhile, he made bold new bets on Mylan (NASDAQ: MYL) and Macy's (NYSE: M).

 

Are you tired of losing money in stocks? Take control of your portfolio with this quick 7-day profit strategy. Click here to get started - 100% free.

 

However, Third Point might be the better play for investors looking to piggyback on hedge funds. Greenlight Capital's fund trades at 97% of book value, while Third Point Reinsurance trades at 86%. Compare that to the 200% of book value that Icahn Enterprises trades at.

 

Third Point is also taking a more cautious approach in 2016, with Loeb noting that his fund has decided to reduce its net exposure to the market.

 

Everyday investors can't invest in hedge funds without having a small fortune tucked away or a salary of more than six figures. However, the publicly listed hedge funds give investors the opportunity to invest with some of the biggest and best hedge fund managers around. It also offers yet another angle for diversification.

 

If you want to use the recent sell-off as a buying opportunity, Loeb's Third Point Reinsurance appears to be the best bet.

 

Good Investing,

 

Marshall Hargrave

Columbus, Ohio

 

Further Reading:

This Junk Food Company Is a Healthy Income Bet

A Low-Cost Airline With Outsized Profit Potential

 

 

How to Access the Best Pre-IPO Investments

 

Investing in IPOs is impossible. Yet the world's best investors know that investing before the IPO is how to make amazing profits! That's why Fidelity and T. Rowe Price are rapidly investing in this sector. You can too…starting right now.

 

Click here for details on this secret opportunity.

 

How to Sleep Easy At Night

 

Is the economy keeping you up at night? Do you worry there's another crash just around the corner? If so, you can stop worrying right now. All it takes is a few minutes.

 

Find out how right here.

 

Popular Analysis from Wyatt Research
 

Tuesday, March 22, 2016
Apple Shares Facing Resistance on Two Fronts as Product Release Underwhelms

Consumers and investors alike have to come to expect big things from Apple (NASDAQ: AAPL) and the company's product announcement events. The company held one on Monday, and by most accounts, the results were underwhelming.

 

Tuesday, March 22, 2016
Options Trading Made Easy: Call Spread Collar

A call spread collar is constructed in the exact same manner as a reverse collar, with one exception: the call purchase is replaced with a call spread. Why would anybody do that, you ask? Well, with a normal reverse collar, the trader buys a protective at-the-money call to ensure against a loss on the trade and, at the same time, sells an at-the-money put to offset the cost of the call.

 

Tuesday, March 22, 2016
How to Make 12.4% in Less Than 2 Weeks Using 'Weeklys'

Do I use weekly options as part of my overall strategy? It's a question I'm often asked. Up until the last few years, it was a question I answered with a resounding, NO. "Weeklys," as they are known in the options world, are not even a decade old. And like most new financial products, it took weeklys a while to grow in popularity. It wasn't until the last five years that weekly options were a viable product.

Latest Daily Profit
 

Tuesday, March 22, 2016
How to Profit From the Chilean Salmon Shortage

By 2050, the world's population is expected to reach 9 billion people. How are we going to feed all those people? One answer is aquaculture. In other words, farmed fish. Aquaculture has been the fastest-growing food production sector over the past 20 years. That growth propelled seafood to become the highest-traded food commodity by value. Today, 3 billion people now receive 20% of their animal protein intake from farmed fish, primarily salmon.

 

Monday, March 21, 2016
DuPont Stock: A Buy in More Ways Than One

DuPont (NYSE: DD) is a hot commodity these days. The chemical giant is planning to merge with Dow Chemical (NYSE: DOW), but could now find itself in a buyout battle. Germany-based BASF SE (OTC: BASFY) is said to be putting together a bid for DuPont. BASF is a bit bigger than both DuPont and Dow, with a market cap of more than $60 billion. It's the third-largest producer of pesticides and insecticides.

If you have any questions about your subscription, please contact Customer Care at 866-447-8625 or 802-448-8410
Monday - Friday between 9:00 a.m. and 5:00 p.m. ET.


Wyatt Investment Research | 65 Railroad Street | Richmond, VT 05477 USA

Toll Free: 866-447-8625 or International: 802-448-8410

Web Site: http://www.wyattresearch.com

Email Customer Service: customerservice@wyattresearch.com

 

Disclaimer & Important Information

WyattResearch.com is owned and published by Wyatt Investment Research. Wyatt Investment Research is neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security.

We encourage you to review our full Email and Disclosure policies.
To view our Email Policy, please
click here. To view our Disclosure Policy, please click here.

If you believe this communication to be a mistake or unsolicited, please e-mail
abuse@bfpnewsletters.com with details regarding your situation, and we will be sure to promptly investigate your situation.

You are subscribed with the following email address: ignoble.experiment@arconati.us
To unsubscribe from this newsletter, please click here.

Copyright (c) 2016 Wyatt Investment Research. |
Privacy Policy

Wyatt Investment Research
65 Railroad Street
Richmond, VT 05477. PO Box 790

 

 

No comments:

Post a Comment

Keep a civil tongue.

Label Cloud

Technology (1464) News (793) Military (646) Microsoft (542) Business (487) Software (394) Developer (382) Music (360) Books (357) Audio (316) Government (308) Security (300) Love (262) Apple (242) Storage (236) Dungeons and Dragons (228) Funny (209) Google (194) Cooking (187) Yahoo (186) Mobile (179) Adobe (177) Wishlist (159) AMD (155) Education (151) Drugs (145) Astrology (139) Local (137) Art (134) Investing (127) Shopping (124) Hardware (120) Movies (119) Sports (109) Neatorama (94) Blogger (93) Christian (67) Mozilla (61) Dictionary (59) Science (59) Entertainment (50) Jewelry (50) Pharmacy (50) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14)

Popular Posts